Natera outlines $2.85B-$2.91B 2026 revenue outlook backed by 31% growth ex true-ups (NASDAQ:NTRA)
Natera (NTRA) Q2 2026 earnings call highlights: record test volumes, Signatera catalysts, raised revenue guidance and margin outlookâread key takeaways now.
YayaNews contributes financial news and market context through the YayaNews editorial workflow.

Natera (NTRA) Q2 2026 earnings call highlights: record test volumes, Signatera catalysts, raised revenue guidance and margin outlookâread key takeaways now.
Natera outlines $2.85B-$2.91B 2026 revenue outlook backed by 31% growth ex true-ups (NASDAQ:NTRA) | Seeking Alpha
Earnings Call Insights: Natera (NTRA) Q2 2026
Management View
CEO Steve Chapman said, âWe processed approximately 1,044,000 tests in the second quarterâ¦setting a new company record,â and highlighted oncology momentum: âwe processed 283,000 clinical MRD unitsâ¦approximately 56%â year-over-year growth, with âthe largest sequential increase to date.â
Seeking Alpha's Disclaimer:
This article was automatically generated by an AI tool based on content available on the Seeking Alpha website, and has not been curated or reviewed by humans. Due to inherent limitations in using AI-based tools, the accuracy, completeness, or timeliness of such articles cannot be guaranteed. This article is intended for informational purposes only. Seeking Alpha does not take account of your objectives or your financial situation and does not offer any personalized investment advice. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank.
To ensure this doesnât happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please
report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.
Search field
Entering text into the input field will update the search result below
Quick Insights
What is driving Natera's record revenue and volume growth?
Growth is powered by Signatera's FDA approval, NCCN guidelines adoption, major commercial investments, increased oncology and clinical test processing, and gains in women's health segment.
How sustainable is Natera's recent growth pace into 2027?
Management is positive on sustaining growth due to investment and adoption catalysts but cautions that Q2 volume was boosted by Q1 disruption and does not expect similar record-setting in the immediate quarters ahead. ASP step-up benefits are mostly expected in 2027.
What are the major margin and pricing risks facing Natera in 2026?
Margin pressure arises from launch-phase new products with unoptimized costs, though cost reduction projects are underway. Major ASP/profit upside from reimbursement and guideline changes are not included in 2026 guidance, being targeted for 2027.
Recommended For You
More
Trending News
See More
»
Original YayaNews editorial coverage, published for informational purposes.
This article is sourced from Seeking Alpha. It is for informational purposes only and does not constitute investment advice.
Topics & Symbols
Continue Reading
Related Reading
HCI outlines over $10M per quarter reinsurance savings as GEICO begins selling new product (NYSE:HCI)
HCI Group (HCI) Q2 2026 earnings call highlights: strong EPS, low combined ratio, reinsurance savings, GEICO distribution and buybacksâread key takeaways.

Nelnet Non-GAAP EPS of $1.77 misses by $0.36 (NYSE:NNI)
Nelnet press release (NNI): Q2 Non-GAAP EPS of $1.77 misses by $0.36.

Riley Exploration Permian Targets 30% Oil Output Growth in 2026, Raises Capex to $236 Million
Riley Exploration Permian's 2026 guidance projects a 30% increase in oil production, with capex midpoint raised to $236 million, focusing on Permian Basin development while balancing growth with shareholder returns.

Dana Announces $200M Buyback and $15B Sales Target for 2030, Partners with Eaton Mobility to Accelerate Electrification
Dana Incorporated unveils a $200 million share repurchase plan and sets a 2030 sales target of $14-15 billion, deepening collaboration with Eaton Mobility to drive electric commercial vehicle systems, showcasing the traditional parts giant's commitment to transformation.
